Clearside Biomedical Inc (NASDAQ:CLSD) has received a consensus recommendation of “Hold” from the eleven research firms that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target […]